Galanin receptor 1 plays an antinociceptive effect via inhibiting PKA activation in the nucleus accumbens of rats with neuropathic pain
Jazyk angličtina Země Česko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
30904004
DOI
10.33549/physiolres.933941
PII: 933941
Knihovny.cz E-zdroje
- MeSH
- aktivace enzymů účinky léků fyziologie MeSH
- analgetika metabolismus MeSH
- bradykinin analogy a deriváty farmakologie MeSH
- galanin analogy a deriváty farmakologie MeSH
- krysa rodu Rattus MeSH
- měření bolesti účinky léků metody MeSH
- neuralgie metabolismus prevence a kontrola MeSH
- nucleus accumbens účinky léků metabolismus MeSH
- peptidové fragmenty farmakologie MeSH
- potkani Sprague-Dawley MeSH
- proteinkinasy závislé na cyklickém AMP antagonisté a inhibitory metabolismus MeSH
- receptor galaninu typ 1 agonisté antagonisté a inhibitory biosyntéza MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- analgetika MeSH
- bradykinin MeSH
- galanin MeSH
- M617 peptide MeSH Prohlížeč
- peptidové fragmenty MeSH
- proteinkinasy závislé na cyklickém AMP MeSH
- receptor galaninu typ 1 MeSH
Galanin and galanin receptors (GalRs) have been reported to be involved in the transmission and modulation of nociceptive information in the central nervous system (CNS). However, the underlying mechanism of the antinociception of GalRs in neuropathic pain remains unclear. This study investigated the antinociception induced by galanin receptor 1 (GalR1) via protein kinase A (PKA) signaling pathway in the nucleus accumbens (NAc) of rats with neuropathic pain. A mononeuropathy model was replicated by ligation of the left sciatic nerve, following which the expression of phospho-PKA (p-PKA) in the NAc were markedly up-regulated at 14(th) and 28(th) day after ligation of sciatic nerve, and p-PKA expression was down-regulated by intra-NAc injection of GalR1 agonist M617, but the GalR1 antagonist M35 did not have an effect. We also found that M35 in the NAc blocked the M617-induced increase in the hind paw withdrawal latencies (HWLs) of rats with mononeuropathy, but M35 alone had no effect on HWLs, and PKA inhibitor H-89 attenuated the M617-induced an increase in the HWLs. These results suggested that GalR1 induced an antinociception via inhibiting PKA activation, implying that GalR agonists may be potential and potent therapeutic options to treat chronic neuropathic pain.
Citace poskytuje Crossref.org